Intel acquired this business when it bought Altera in 2015, but it has regained interest (and growth) thanks to its exposure to certain applications in the field of artificial intelligence. While the demerger is due to be finalized in January 2024, the IPO may not take place until two or three years later. processor giant plans to spin off its Programmable Solutions Group (PSG) before its IPO. The IPO, entrusted to Rothschild, could take place in 2024. Even so, the division could be worth 20 billion euros. Like others ( GSK with Haleon, for example), Sanofi is giving in to the siren calls of demerger for an activity that is showing weak growth and lower margins than its core business. Sanofi Consumer Products (Sanofi): Sanofi Grand Public is the consumer healthcare division of the French laboratory. The latter wishes to retain a majority stake in Syngenta post-IPO. Subsequently, the former joint venture between AstraZeneca and Novartis was integrated into the giant Sinochem. Its intention remains to return to the stock market, having left it when it was bought by ChemChina in 2017 for $43bn. The company has postponed an operation planned for this year in Shanghai, which could have valued it at $60 billion. Syngenta (Sinochem): Syngenta is a leading agrochemicals and seeds company, originally from Switzerland. Shein has yet to determine its valuation, but Bloomberg reported in early November that the group hoped to be valued at up to $90 billion, having achieved a price of $66 billion in a round of financing carried out last May. The group has already filed a pre-proposal for an IPO in the United States, which could make it one of the largest Chinese companies in terms of capitalization listed in New York. Shein: Shein is a Chinese e-commerce company specializing in fashion, which has captured the hearts of fashionistas the world over by drowning them in a heap of low-priced clothing. CATL is currently worth the equivalent of just over $90 billion on its domestic market. CATL therefore turned to Hong Kong to gain access to international investors. Beijing takes a dim view of Western listings, which take precedence over A-share trading on the Shanghai and Shenzhen stock exchanges. ![]() Earlier this year, a project to list certificates in Switzerland failed after administrative problems. But it has its sights set on more outward-looking markets. This would make it the biggest American deal of the year, and perhaps even of the decade, surpassed only by Saudi Aramco and Alibaba on a global scale.Ĭontemporary Amperex Technology: The world's largest manufacturer of batteries for electric vehicles by far is already listed on the Shenzhen stock exchange. However, based on the latest financing rounds, the deal could be worth $180 billion. ![]() There have been recurring rumors of this, but Musk himself has denied it. SpaceX: The space division of the Elon Musk galaxy is something of a wild card IPO for 2024.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |